Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02136134 · COMPLETED
Trial details
- NCT number
- NCT02136134
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-15
- Primary completion
- 2016-01-11
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.